Skip to main content
. 2023 Apr 25;2023(4):CD013871. doi: 10.1002/14651858.CD013871.pub2

1.12. Analysis.

1.12

Comparison 1: Fecal microbiota transplantation (FMT) versus control for the treatment of recurrent Clostridioides difficile infections (rCDI), Outcome 12: All‐cause mortality: sensitivity analysis: excluding immunocompromised participants